Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Human cytomegalovirus wikipedia , lookup
Swine influenza wikipedia , lookup
Taura syndrome wikipedia , lookup
Avian influenza wikipedia , lookup
Foot-and-mouth disease wikipedia , lookup
Marburg virus disease wikipedia , lookup
Influenza A virus wikipedia , lookup
Hepatitis B wikipedia , lookup
Orthohantavirus wikipedia , lookup
Canine distemper wikipedia , lookup
KEY POINTS IN FINE TUNING THE USE OF A SPECIFIC VACCINE AGAINST VERY VIRULENT INFECTIOUS BURSAL DISEASE D.r Marcos Bentué, p oultry technical services department, Laboratorios Hipra, S.A. Spain Specific vaccines against infectious bursal disease (IBD) offer satisfactory solutions to most problems in which the very virulent IBD virus (vvIBD) is implicated. They provide a next step after the mild and intermediate vaccines in the control of IBD and have proved to be effective in reducing mortality caused by the disease. However, poultry veterinarians and producers are sometimes hesitant to administer this kind of product because of past experience when the application of too ‘hot’ vaccines irreversibly damaged the bird’s immune system. Nowadays, there is a wide range of this type of vaccine available on the market, although there is a tendency to choose products that are safer and less damaging to the bursa. This article provides some insights into the technical characteristics of specific IBD vaccines, with a view to using them more effectively to control vvIBD. The term ‘specific’ refers to the specificity that the vaccine virus shows to neutralise vvIBD viruses without causing the bursal damage that some other ‘hot’ vaccines cause. Back to basics When dealing with IBD problems, the first step is to decide the appropriate place and time to switch the IBD vaccines. The use of a specific vaccine should only be considered when abnormally high mortality is experienced that is clearly related to IBD and that cannot be controlled with intermediate vaccines. Starting with the basics, an IBD control programme should always be followed, based on chicks hatched with adequate levels of maternal antibodies, appropriate vaccination time and good cleaning/disinfection programmes. If, after revision of all these points, IBD problems are still unmanageable, the decision may be taken to extend the range of vaccines under consideration to include the specific type. Step 1: Identify the enemy However, before proceeding in this direction, it is essential to identify the characteristics of the viruses circulating on the farm. It is not a good idea to introduce specific vaccines against vvIBD virus if the viral strains present can be controlled with mild or intermediate vaccines and/or the implementation of better management practices. To this end, various molecular diagnostic tools are available not only to confirm the presence of the IBD virus but also to identify specific traits of the strains. For instance, RT/PCR-RFLP (reverse transcriptase/polymerase chain reaction-restriction fragment length polymorphisms) is able to: - detect all IBD strains independently of their level of pathogenicity and antigenicity - differentiate most vaccine strains from wild-type field viruses - determine virulent strains of the virus and fit the strains into molecular groups. Differentiation of vvIBDV (very virulent IBD) from cvIBDV (classic virulent IBD). Restriction enzyme BspMI “cuts” very virulent IBD (lane 3) while does not have any effect on the classic virulent IBD (lane 7) . Restriction enzyme SacI does not “cut” vvIBD (lane 2) while it does in lane 6 (cvIBD). Thus allowing the identification of both IBD viruses. RT-PCR followed by enzymatic digestion allows us to discriminate between the very virulent and classic virulent strains of IBD (cvIBD), as shown in Figure 1. Subsequently, the sequencing of the PCR products allows further characterisation of the virus. In the example in Figure 1, restriction enzyme BspMI cuts vvIBD virus (lane 3), while it does not affect the cvIBD virus in lane 7. Restriction enzyme SacI does not cut vvIBD virus (lane 2), while it does cut the cvIBD strain in lane 6. This allows the two viruses to be identified and distinguished. Routine monitoring of poultry flocks by RT-PCR is highly recommended in order to assess the IBD viruses circulating on the farm and to finetune the vaccination programme. For flocks facing IBD, 5 to 10 bursas should be submitted to a well-equipped laboratory to identify the characteristics of the IBD virus present in the flock. For effective control of IBD, it is essential to know beforehand which viruses you are facing. Step 2: Get the timing for vaccination right Once the involvement of vvIBD virus is confirmed and the decision is made to administer the vaccine, the next step is to determine the best vaccination time. It is well known that maternal immunity might protect the birds against the field virus during the first weeks of life. The disadvantage is that the maternal immunity may also interfere with the vaccine virus if vaccination is carried out too early. Maternal immunity should be seen as a kind of temporary ‘wall’ that is very thick at the hatching time but it declines linearly at a predictable rate afterwards. At a certain point, this ‘wall’ will have become sufficiently thin for the vaccine virus to penetrate and for active immunity to be developed. However, if IBD vaccines are administered too early, they bump against the ‘wall’ and thus, they are neutralised and become ineffective in vaccinating the flock as a whole. Vaccine neutralisation can be avoided by delaying vaccination until the chicks become susceptible to the vaccine and are able to respond to the vaccine virus. However, this opens up the possibility of an ‘immunity gap’, when the field virus can penetrate before some intermediate vaccine viruses. In order to maintain the bird’s good health, the vaccine virus must get there first. After bypassing maternal immunity, the vaccine viruses colonise the bursal tissue and replicate fast, while humoral and cellular immunity are developing. In addition, they compete with the field virus for the bursal attachment sites. Generally, specific IBD vaccines can be administered earlier and the susceptibility period to the field virus is shorter. A further advantage of specific IBD vaccines is that they are more diffusible. This means that calculation of the proper vaccination time is less critical than with intermediate vaccines. The latter can allow the vaccine virus to spread to the unvaccinated chicks. However, it is still recommended to avoid the unwanted neutralisation and to achieve the maximum potential from the vaccine. In order to estimate the optimal vaccination time, blood samples should be collected from 18 to 20 healthy, one-day-old chicks. Estimations based on fewer samples are unreliable and are a false economy. The serum should be submitted to the laboratory, which will provide the level of titres, coefficient of variation (CV) and vaccination time. The prediction of vaccination time is made based on calculation using one of several formulae available, e.g. Kouwenhoven or Deventer. Regular monitoring of day-old chicks is recommended to predict the best time of vaccination. The example in Figure 2 shows a good level of titre and high uniformity and so the chicks will be protected with a single vaccination at 12 days of age. If the results show low titres and/or a high co-efficient of variation, it may be necessary to vaccinate the flock twice. A word of caution is necessary here. The mathematical formulae do not take into account all the variables on a particular farm. Vaccination time should be adjusted to allow for the special circumstances of the flock. Allowances might need to be made, for example, for: - broiler flocks originating from different sources and consequently with heterogeneous maternal titres and - multi-age farms where chicks are exposed to high levels of vvIBD virus upon arrival. Other considerations It has already been mentioned that specific IBD vaccine viruses are more diffusible than those in the intermediate type of vaccine. This means that in-house cycling is a common phenomenon. After replicating in the bursa, the viruses are shed onto the litter and may be ingested again, reinforcing the immune status of the same bird or passing on toother chicks that were poorly vaccinated. This cycling may continue for several days after vaccination. It is said that the specific type of IBD vaccine is more forgiving when the vaccination is not doneproperly. However, it is important not to rely on this phenomenon and relax over vaccination practices because this can jeopardise protection levels and allow IBD to break out again. This risk is higher for pullet flocks confined to rearing cages as they cannot access their faeces and the IBD vaccine virus cannot circulate in this way. Technically speaking, specific IBD vaccines are more invasive to the bursa and even replicate to some extent in other lymphoid tissues, e.g. caecal tonsils, spleen, Harderian glands. This means that earlier and higher levels of ELISA titres are seen after the administration of these vaccines. It is not recommended that specific IBD vaccines are administered continuously. After vaccination of several batches of birds with specific vaccines, IBD problems will, in most cases, be overcome and the field virus may even have been displaced. As a result, the possibility of stepping down to vaccines of intermediate type should be evaluated. To summarise, specific IBD vaccines can effectively control field cases of vvIBD. However, some technical guidelines should be followed, in order to optimise the protection conferred by the vaccines. In addition, good use should be made of the available diagnostic techniques, which are invaluable tools in helping to reach the most appropriate decisions. Elisa testing of 20 serum samples of broiler day old chicks to assess the maternal antibodies level 100.00 90.00 Frequency 80.00 70.00 Age at sampling: Number of Samples: Arithmetic Mean Titre: CV % Geometric Mean Titre: Predicted vaccination time: 60.00 50.00 40.00 30.00 20.00 10.00 0.00 0 1 2 3 4 5 6 7 8 9 Titre Group 10 11 12 13 14 15 1 day 20 6600 27 % 5950 12 days